WallStreetZenWallStreetZen

NASDAQ: DYN
Dyne Therapeutics Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

DYN earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$235.9M
Current Profit Margin
0%

DYN Return on Equity

Current Company
-136.4%
Current Industry
-63.5%
Current Market
188%
DYN's Return on Equity (-136.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when DYN announces earnings.

DYN Return on Assets

Current Company
-103.7%
Current Industry
2.9%
DYN is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

DYN Return on Capital Employed

Current Company
-206.99%
Current Industry
19.5%
DYN's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

DYN vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
DYN$0.00-$233.48M-$235.94MN/AN/A
CLDX$6.88M-$138.42M-$141.43M-6.32%N/A
KYMR$78.59M-$143.20M-$146.96M+127.50%N/A
NTLA$36.28M-$472.22M-$481.19M+3.57%N/A
RCKT$0.00-$236.62M-$245.60MN/AN/A
View Top Biotech Stocks

DYN earnings dates

Next earnings date
May 22, 2024

Dyne Therapeutics Earnings & Revenue FAQ

What were DYN's earnings last quarter?

On Invalid Date, Dyne Therapeutics (NASDAQ: DYN) reported Q4 2023 earnings per share (EPS) of -$1.09, up 49.32% year over year. Total Dyne Therapeutics earnings for the quarter were -$66.64 million. In the same quarter last year, Dyne Therapeutics's earnings per share (EPS) was -$0.73.

If you're new to stock investing, here's how to buy Dyne Therapeutics stock.

What was DYN's earnings growth in the past year?

As of Q2 2024, Dyne Therapeutics's earnings has grown year over year. Dyne Therapeutics's earnings in the past year totalled -$235.94 million.

What is DYN's earnings date?

Dyne Therapeutics's earnings date is Invalid Date. Add DYN to your watchlist to be reminded of DYN's next earnings announcement.

What was DYN's revenue last quarter?

On Invalid Date, Dyne Therapeutics (NASDAQ: DYN) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Dyne Therapeutics's revenue was $0.00.

What was DYN's revenue growth in the past year?

As of Q2 2024, Dyne Therapeutics's revenue has grown null year over year. Dyne Therapeutics's revenue in the past year totalled $0.00.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.